DR JOHN HOLT'S UHF RESONANCE – ELECTROMAGNETIC IMPLICATIONS – CANCER AND HIV AN HYPOTHESIS (Number 4)

Dr John Holt (Radiotherapist, Western Australia) trialedradiowave UHF 434 MHz (+oxidizing agent) to treat patients with cancer and human immunodeficiency virus (HIV+), initially using dipole-based antennae, later with loop antennae. He noted that, with the change, the resonance display, a point for objectivity, was diminished/lost. The claimed change in spectral emission is discussed with reference to quantum effects and a proposed explanation for the claimed benefits of UHF for HIV+ and other future viral and Prion disease patients. Conclusion: Holt’s UHF treatment may benefit both cancer and HIV+ patients.